Predicted to enable translation initiation factor activity. Predicted to be involved in translational initiation. Predicted to be located in nucleus. Predicted to be part of eukaryotic translation initiation factor 3 complex. Expressed in head and tail. Is an ortholog of human EIF3E (eukaryotic translation initiation factor 3 subunit E).
Predicted to enable prostaglandin-E synthase activity. Predicted to be involved in cellular oxidant detoxification; glutathione metabolic process; and prostaglandin biosynthetic process. Predicted to be located in mitochondrion. Expressed in hypodermis; intestinal cell; lumbar ganglion; muscle cell; and retrovesicular ganglion. Is an ortholog of human PTGES2 (prostaglandin E synthase 2).
Predicted to enable nitrilase activity and nitrile hydratase activity. Predicted to be involved in detoxification of nitrogen compound. Expressed in several structures, including E; Ea; Ep; MSaa; and MSpa.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in endodermal cell fate specification and mesodermal cell fate specification. Located in nucleus. Expressed in E; E lineage cell; Ea; Ep; and intestine.
Predicted to enable aspartic-type endopeptidase activity. Predicted to be involved in proteolysis. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).